Cubist Systematic Strategies’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$788K Buy
+30,446
New +$705K ﹤0.01% 2059
2025
Q1
Sell
-154,512
Closed -$3.9M 2931
2024
Q4
$3.9M Buy
+154,512
New +$4.2M 0.02% 978
2024
Q2
Sell
-67,434
Closed -$2.83M 3122
2024
Q1
$2.83M Buy
+67,434
New +$2.77M 0.02% 1370
2023
Q3
Sell
-11,460
Closed -$389K 3410
2023
Q2
$389K Buy
11,460
+8,678
+312% +$292K ﹤0.01% 2522
2023
Q1
$100K Buy
2,782
+1,226
+79% +$52.9K ﹤0.01% 3437
2022
Q4
$69.4K Buy
1,556
+1,547
+17,189% +$55.2K ﹤0.01% 3858
2022
Q3
$0 Buy
+9
New +$276 ﹤0.01% 4449
2022
Q2
Sell
-12,633
Closed -$430K 4378
2022
Q1
$430K Sell
12,633
-16,353
-56% -$523K ﹤0.01% 2625
2021
Q4
$1.12M Buy
28,986
+7,063
+32% +$308K 0.01% 1835
2021
Q3
$1.18M Sell
21,923
-972
-4% -$45.6K 0.01% 1389
2021
Q2
$766K Sell
22,895
-2,206
-9% -$60.6K 0.01% 1739
2021
Q1
$517K Buy
+25,101
New +$576K 0.01% 1936
2018
Q2
Sell
-6,134
Closed -$214K 1820
2018
Q1
$214K Buy
6,134
+3,141
+105% +$122K 0.01% 1358
2017
Q4
$128K Buy
2,993
+641
+27% +$27.5K 0.01% 1648
2017
Q3
$101K Buy
+2,352
New +$88.2K 0.01% 1626
2017
Q1
Sell
-854
Closed -$45K 1655
2016
Q4
$45K Sell
854
-921
-52% -$52.4K ﹤0.01% 1591
2016
Q3
$108K Buy
1,775
+398
+29% +$24.8K 0.01% 1446
2016
Q2
$91K Buy
+1,377
New +$87.4K 0.01% 1523
2016
Q1
Sell
-726
Closed -$171K 1632
2015
Q4
$171K Sell
726
-2,042
-74% -$445K 0.01% 1403
2015
Q3
$438K Buy
2,768
+2,141
+341% +$606K 0.02% 1035
2015
Q2
$237K Sell
627
-902
-59% -$358K 0.01% 1351
2015
Q1
$639K Buy
+1,529
New +$547K 0.03% 792
2014
Q3
Sell
-1,009
Closed -$247K 1746
2014
Q2
$247K Buy
+1,009
New +$228K 0.01% 1050

Other funds holding CLDX